Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor
Not Applicable
Active, not recruiting
- Conditions
- GlaucomaGlaucoma, Open-Angle
- Registration Number
- NCT05127551
- Lead Sponsor
- Glaukos Corporation
- Brief Summary
A study of the iStent Infinite product in the treatment of open-angle glaucoma vs competitor
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 179
Inclusion Criteria
- Diagnosis of Primary Open-Angle Glaucoma (POAG) or Secondary Pseudoexfoliative Glacoma (PEXG) or Secondary Pigmentary Glaucoma (PG)
Exclusion Criteria
- Any other type of glaucoma including, but not limited to: traumatic glaucoma, angle recession glaucoma, uveitic glaucoma, neovascular glaucoma, angle closure glaucoma (ACG) and glaucoma associated with vascular disorders
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in Mean Diurnal Intraocular Pressure Month 24 Change in Mean Diurnal Intraocular Pressure from Baseline over time
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Glaukos Investigator Sites
🇨🇦Montréal, Qubec, Canada
Glaukos Investigator Sites🇨🇦Montréal, Qubec, Canada